Tag: ANVISA

Nemera's Lifepen to treat diabetic patients in Brazil

Nemera & Biomm partner to Commercialize Reusable Insulin Pen in Brazil

HTP Desk - 0
A pioneer in biotechnological medicines in Brazil, Biomm is launching Nemera’s Advapen under the trade name Lifepen to administer Glargilin insulin for the treatment...
Clilon: Nemera's preservative-free formulation

Nemera’s preservative-free multi-dose eye dropper Novelia approved

HTP Desk - 0
Nemera is excited to announce that its multi-dose eye dropper Novelia has been approved by ANVISA for the preservative-free formulations Clilon (Ketorolac 0,4%...